Semaglutide, a long-acting GLP-1 receptor agonist with a half-life of approximately one week, has demonstrated significant efficacy across at least four distinct therapeutic indications, including type 2 diabetes mellitus, chronic weight management in adults with obesity or overweight, reduction of major adverse cardiovascular events in patients with established cardiovascular disease, and emerging indications in metabolic dysfunction-associated steatotic liver disease (MASLD)
For patients discontinuing Wegovy, whether due to achieving weight goals, experiencing adverse effects, or other medical reasons, it's essential to understand that the medication's effectsboth therapeutic and potential side effectsmay persist for several weeks after the last injection
Its antioxidant action helps to safeguard the hair follicles from damage, promoting a healthy environment for hair growth and preserving hair color by protecting the melanin in the hair shaft
No exceptions, no autopilot
There arent any direct drug interactions between semaglutide injections and standard thyroid medications, such as Synthroid (levothyroxine) and Armour thyroid (desiccated thyroid hormone), says Lauren Cunningham, Pharm.D., another clinical pharmacist with the University of Illinois Hospital and Health Sciences System
Side effects can include nausea and gastrointestinal symptoms, but these are often temporary and manageable